1. Impact of the 13-valent conjugated pneumococcal vaccine on the direct costs of invasive pneumococcal disease requiring hospital admission in children aged < 5 years: a prospective study
- Author
-
Ignacio Aznar-Lou, Juan José García-García, E. Navas, Sebastià González-Peris, Fernando A. Moraga-Llop, Johanna Martínez-Osorio, Angela Domínguez, Mariona Fernández de Sevilla, Sergi Hernández, Luis Salleras, Magda Campins, Cristina Esteva, Pilar Ciruela, Mireia Jané, Conchita Izquierdo, Gemma Codina, Ana María Planes, Carmen Muñoz-Almagro, Antoni Serrano-Blanco, and Sonia Uriona
- Subjects
Serotype ,Vacunas ,Pediatrics ,lcsh:Medicine ,Children -- Health and hygiene ,PCV13 ,Vacunes ,Health services ,Indirect costs ,0302 clinical medicine ,direct cost ,Drug Discovery ,Medicine ,Pharmacology (medical) ,030212 general & internal medicine ,Costes ,Prospective cohort study ,Children ,Vaccines ,Pneumococs ,PCV7 ,Pneumococcus ,Hospitals -- Ingressos i altes ,Infectious Diseases ,Hospital admission ,Meningitis ,Infants ,Niños -- Salud e higiene ,medicine.medical_specialty ,Pneumococcal disease ,Cost ,030231 tropical medicine ,Immunology ,Hospitals -- Admissions and discharges ,invasive pneumococcal disease ,Article ,Hospitales -- Admisión y alta ,03 medical and health sciences ,Neumococos ,Infants -- Salut i higiene ,Pharmacology ,business.industry ,lcsh:R ,Pneumococcal vaccine ,medicine.disease ,Vacuna antipneumocòccica ,Costs ,business - Abstract
The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the eect of pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate the direct costs of hospitalized IPD cases. A prospective study was made in children aged
- Published
- 2020